These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24142670)

  • 1. Revascularization in heart failure in the post-STICH era.
    Jha S; Flamm SD; Kwon DH
    Curr Heart Fail Rep; 2013 Dec; 10(4):365-72. PubMed ID: 24142670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era.
    Shah BN; Khattar RS; Senior R
    Eur Heart J; 2013 May; 34(18):1323-36. PubMed ID: 23420867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The world post STICH: is this a "Game Changer?" A surgeon's perspective--revascularization is still the treatment of choice.
    Daggubati R; Arumugham P; Ferguson TB
    Prog Cardiovasc Dis; 2013; 55(5):470-5. PubMed ID: 23518374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of revascularization in chronic heart failure.
    Gurunathan S; Ahmed A; Senior R
    Curr Heart Fail Rep; 2015 Apr; 12(2):112-9. PubMed ID: 25500783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Viability Testing to Guide Coronary Revascularization.
    Löffler AI; Kramer CM
    Interv Cardiol Clin; 2018 Jul; 7(3):355-365. PubMed ID: 29983147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
    O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R;
    Trials; 2013 Jul; 14():218. PubMed ID: 23866673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and therapeutic implications of myocardial viability in patients with heart failure.
    Soman P; Udelson JE
    Curr Cardiol Rep; 2004 May; 6(3):211-6. PubMed ID: 15075058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of revascularization to improve left ventricular function.
    Patel HC; Ellis SG
    Heart Fail Clin; 2015 Apr; 11(2):203-14. PubMed ID: 25834970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Velazquez EJ; Lee KL; O'Connor CM; Oh JK; Bonow RO; Pohost GM; Feldman AM; Mark DB; Panza JA; Sopko G; Rouleau JL; Jones RH;
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1540-7. PubMed ID: 18023680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Revascularization of the hibernated myocardium: a clinical problem still unsolved].
    Ammirati E; Guida V; Rimoldi OE; Camici PG
    G Ital Cardiol (Rome); 2012 Feb; 13(2):102-9. PubMed ID: 22322550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ischemic cardiomyopathy: possibilities of surgical treatment].
    Benetis R; Simukauskiene A; Jankauskiene L; Kavoliūniene A
    Medicina (Kaunas); 2007; 43(11):909-17. PubMed ID: 18084150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The STICH trial: misguided conclusions.
    Buckberg GD; Athanasuleas CL
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1060-1064.e2. PubMed ID: 19837213
    [No Abstract]   [Full Text] [Related]  

  • 17. The hibernating heart: reversible left ventricular dysfunction in chronic heart failure.
    Burn S; Walters M; Caplin J
    Postgrad Med J; 1999 Jul; 75(885):419-21. PubMed ID: 10474727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance imaging for detection of myocardial viability in chronic ischemic left ventricular dysfunction.
    Glaveckaite S; Valeviciene N; Laucevicius A; Celutkiene J; Rudys A; Tamosiūnas A
    Medicina (Kaunas); 2009; 45(8):585-99. PubMed ID: 19773617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability by MRI or PET would have changed the results of the STICH trial.
    Srichai MB; Jaber WA
    Prog Cardiovasc Dis; 2013; 55(5):487-93. PubMed ID: 23518377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viability by MRI or PET would not have changed the results of the STICH trial.
    Asrani NS; Chareonthaitawee P; Pellikka PA
    Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.